38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred treatment for S. maltophilia BSI. Hematologic malignancy patients are at increased risk of S. maltophilia BSI but because of the TMP-SMX adverse event profile, this agent is not routinely included in empiric treatment regimens. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaba, Sara M, Amoah, Joe, Cosgrove, Sara E, Tamma, Pranita D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776099/
http://dx.doi.org/10.1093/ofid/ofaa417.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776099/
http://dx.doi.org/10.1093/ofid/ofaa417.037

Ejemplares similares